Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Male breast cancer: experience from a Malaysian tertiary centre

< Back to Listing

Share this Article

Singapore Med J 2009; 50(5): 519-521
Male breast cancer: experience from a Malaysian tertiary centre

  • Abstract
  • PDF

Ngoo KS, Rohaizak M, Naqiyah I, Shahrun Niza AS
Correspondence: Prof Rohaizak Muhammad, rohaizak@hotmail.com

ABSTRACT
Introduction
Breast cancer is a rare condition among men with a reported incidence of about one percent. Nevertheless, it is thought to behave similarly in both genders. Due to its rarity, male breast cancer is not widely reported, especially in the Asian population.
Methods In a five-year review of our breast cancer surgery series, about 1.6 percent involved male patients. There was a substantial delay in presentation among those men, whose mean age at presentation was 64 years.
Results The majority of patients presented with a painless lump. Histologically, all tumours were ductal in origin and all patients had lower than stage III malignancies. The majority of patients underwent mastectomy and axillary lymph node dissection. All male patients were commenced on adjuvant tamoxifen. The longest survival was 54 months with all patients remaining tumour-free.
Conclusion Malaysian men are at risk of breast cancer and seem to have a better prognosis.

Keywords: breast carcinoma, male breast carcinoma, male breast lump
Singapore Med J 2009; 50(5): 519-521

http://smj.org.sg/sites/default/files/5005/5005a12.pdf
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.